Faculty, Staff and Student Publications
Language
English
Publication Date
12-1-2025
Journal
Cancer Research
DOI
10.1158/0008-5472.CAN-25-2024
PMID
40966362
PMCID
PMC12515478
PubMedCentral® Posted Date
10-13-2025
PubMedCentral® Full Text Version
Author MSS
Abstract
KRASG12C inhibitors (G12Ci) have produced encouraging, albeit modest and transient, clinical benefit in pancreatic ductal adenocarcinoma (PDAC). Identifying and targeting resistance mechanisms to G12Ci treatment is therefore crucial. To better understand the function of KRASG12C and possible G12Ci bypass mechanisms, we developed an autochthonous KRASG12C-driven PDAC model. Compared to the classical KRASG12D PDAC model, the G12C model exhibits slower tumor growth, yet similar histopathological and molecular features. Aligned with clinical experience, G12Ci treatment of KRASG12C tumors produced modest impact despite stimulating a ‘hot’ tumor immune microenvironment. Immunoprofiling revealed that CD24, a ‘don’t eat me’ signal, is significantly upregulated on cancer cells upon G12Ci treatment. Blocking CD24 enhanced macrophage phagocytosis of cancer cells and significantly sensitized tumors to G12Ci treatment. Similar findings were observed in KRASG12D-driven PDAC. Together, this study reveals common and distinct oncogenic KRAS allele-specific biology and identifies a clinically actionable adaptive mechanism that may improve the efficacy of oncogenic KRAS inhibitor therapy in PDAC.
Keywords
CD24 Antigen, Proto-Oncogene Proteins p21(ras), Pancreatic Neoplasms, Animals, Mice, Humans, Carcinoma, Pancreatic Ductal, Tumor Microenvironment, Cell Line, Tumor, Xenograft Model Antitumor Assays, Signal Transduction, Mice, Transgenic, Mutation
Published Open-Access
yes
Recommended Citation
Wei, Yongkun; Liu, Minghui; Yen, Er-Yen; et al., "KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer" (2025). Faculty, Staff and Student Publications. 5533.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5533
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons